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Abstract
Background: The Sulfs are a family of endosulfatases that selectively modify the 6O-sulfation state of cell-surface heparan
sulfate (HS) molecules. Sulfs serve as modulators of cell-signaling events because the changes they induce alter the cell
surface co-receptor functions of HS chains. A variety of studies have been aimed at understanding how Sulfs modify HS
structure, and many of these studies utilize Sulf knockout cell lines as the source for the HS used in the experiments.
However, genetic manipulation of Sulfs has been shown to alter the expression levels of HS biosynthetic enzymes, and in
these cases an assessment of the fine structural changes induced solely by Sulf enzymatic activity is not possible. Therefore,
the present work aims to extend the understanding of substrate specificities of HSulf2 using in vitro experiments to
compare HSulf2 activities on HS from different organ tissues.
Methodology/Principal Findings: To further the understanding of Sulf enzymatic activity, we conducted in vitro
experiments where a variety of mammalian HS substrates were modified by recombinant human Sulf2 (HSulf2). Subsequent
to treatment with HSulf2, the HS samples were exhaustively depolymerized and analyzed using size-exclusion liquid
chromatography-mass spectrometry (SEC-LC/MS). We found that HSulf2 activity was highly dependent on the structural
features of the HS substrate. Additionally, we characterized, for the first time, the activity of HSulf2 on the non-reducing end
(NRE) of HS chains. The results indicate that the action pattern of HSulf2 at the NRE is different compared to internally within
the HS chain.
Conclusions/Significance: The results of the present study indicate that the activity of Sulfs is dependent on the unique
structural features of the HS populations that they edit. The activity of HSulf2 at HS NREs implicates the Sulfs as key
regulators of this region of the chains, and concomitantly, the protein-binding events that occur there.
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Introduction
Cell surface heparan sulfate (HS) regulates a multitude of
biochemical events including homeostasis, inflammation, angio-
genesis, differentiation, and proliferation [1,2]. These linear
carbohydrates are expressed as a mixture of glycoforms of varying
length and primary sequence [3]. The complexity of HS chains is
derived from their non-template driven biosynthesis, but despite
this, certain structural elements remain consistent in HS
populations from a given tissue among different individuals [4].
How the expression of conserved structural elements is controlled
is not clear from the enzymatic steps that assemble HS.
Biosynthesis begins in the Golgi by addition of alternating GlcNAc
and GlcA units to a linker tetrasaccharide on a core protein [5].
The elongating chains are modified by replacement of a subset of
N-acetates with N-sulfate and epimerization of some GlcA residues
to IdoA. O-sulfotransferases also modify the chains, most
commonly at the 2O-position of IdoA and the 6O-positions of
GlcNAc and GlcNS. The end result is a domain structure
consisting of regions of high N-sulfation (NS domains), high N-
acetylation (NA domains), and alternating N-substitutions (NA/NS
domains). It is the structure and organization of these domains,
particularly the NS domains [6], that is responsible for the protein-
binding abilities of HS. The modifications conferred during HS
biosynthesis were thought to be the sole determinants of HS
structure until the discovery of the cell surface HS editing enzymes
known as the Sulfs [7].
The avian enzyme QSulf1 was the first Sulf family member to
be identified, and the importance of this discovery was
underscored by the ability of the enzyme to modulate Wnt
signaling in developing quail embryos [8]. QSulf1 possesses a
sequence with high homology to the catalytic domain of
GlcNR6ase, a lysosomal glucosamine exosulfatase that functions
in 6O-desulfation during HS degradation. Subsequently, murine
and human Sulf1 isoforms were identified, in addition to a related
family member, Sulf2 [9]. These enzymes were shown to catalyze
removal of 6O-sulfate groups from glucosamine residues of heparin
with maximal activity near neutral pH. Despite the homology of
the Sulfs to GlcNR6ase, there were a number of key differences
that carried important biochemical implications. First, the Sulfs
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ally, they had an N-terminal secretion signal peptide and contained
a unique hydrophilic domain that could interact with cell surface
components [8]. The hydrophilic domain was shown to be a
critical component for the function of the Sulfs, in that it was
essential for cell-surface attachment, substrate binding, and
catalytic activity [10].
A number of studies have characterized the context in which
Sulfs edit the 6O-sulfation pattern of HS. QSulf1 was shown to
release 6O-sulfate from both IdoA2S-GlcNS6S and GlcA-
GlcNS6S, disaccharides known to originate from NS domains
[11]. IdoA-GlcNS6S, however, was not a QSulf1 target, nor were
any 6O-sulfates located in NA/NS domains [12]. Investigations
into mammalian Sulfs have yielded slightly different substrate
specificities. For example, the murine Sulfs have been shown to
alter the 6O-sulfation state of NA/NS domains of HS in vivo
[13,14], but not in vitro [14].
The release of 6O-sulfates by the Sulfs with respect to the total
sulfate content of HS (the sum of all N- and O-sulfates), has been
estimated as 5–7% from in vitro experiments using QSulf1 [15].
These changes, though relatively small in magnitude, have been
associated with alterations in the binding of HS to extracellular
signaling molecules. In the cases of GDNF [16], BMP [12], Shh
[17,18], and Wnt [15,19], Sulfs serve as positive regulators and
enhance signaling. The opposite is true for FGF2 [14,20], HB-
EGF [21], HGF [22], and TGF-b [23]. The long list of important
growth factors and morphogens, the activities of which are
modulated by the Sulfs, indicates the important roles of these
extracellular HS editors in proliferation, migration, and differen-
tiation. Depending on the context, Sulfs can serve as oncogenic
effectors or tumor suppressors, and reports detailing the role of
Sulfs in cancer are numerous [21,22,24,25,26,27]. Most recently,
Sulf2 was identified as a transcriptional target of the tumor
suppressor p53 [28].
In light of findings that changes in Sulf expression levels
influence HS biosynthesis [29], the aim of the current study was to
extend knowledge of Sulf modification of HS by analyzing various
HS substrates that have been modified by recombinant human
Sulf2 (HSulf2). These studies aimed to understand how Sulfs edit
HS isolated from different a certain tissue contexts, and the use of
a purified enzyme preparation eliminated the variables, such as
altered expression of HS biosynthetic enzymes, that confounded
the study of Sulf activity in Sulf over-expressing or knockout
animals or cell lines. The current experiments also provided the
first assessment of HSulf2 activity at HS chain termini, regions that
have been implicated in biochemically important protein-binding
events that control developmental processes.
Results
The activity of HSulf2 on various bovine HS substrates was
examined by disaccharide analysis using size-exclusion liquid
chromatography-mass spectrometry (SEC-LC/MS), a technique
that has previously been applied to the analysis of HS
disaccharides from mammalian organs [30,31]. The bovine
samples included HS from lung, intestine, aorta, and two fractions
from kidney that were purified using two different concentrations
of salt (1.1 M or 1.25 M NaCl) for elution from anion exchange
chromatography [11]. The samples were digested exhaustively
with HSulf2 and then subjected to exhaustive depolymerization
using a mixture of heparin lyases I, II, and III. These conditions
generate an array of disaccharides, designated subsequently using
the structural code of Lawrence and Esko [32]. This alphanumeric
code (see Fig. S1) consists of four digits that designate the
structures of the uronic acid and glucosamine that comprise each
disaccharide. The first position specifies whether the uronic acid is
saturated (U) or D
4,5-unsaturated (D). The second digit specifies
whether the uronic acid is unmodified (0) or modified by 2O-
sulfation (2). The third digit specifies whether the glucosamine is
N-acetylated (A) or N-sulfated (S). The fourth digit specifies
whether the glucosamine is unmodified (0) or modified by 6O-
sulfation (6). For example, D2S0 specifies the structure delta-
uronic acid-2-sulfate-N-sulfoglucosamine and U0A6 specifies the
structure uronic acid-N-acetylglucosamine-6-sulfate.
The SEC LC/MS method generated disaccharide analysis
profiles consistent with those from other methods while producing
additional information on NRE disaccharides and low abundance
disaccharides containing an unmodified glucosamine primary
amino group. For example, the SEC LC/MS method measured
the abundance of the D2S6 disaccharide in rat brain as 4.260.1%
[33]. This value is consistent with the 3.9-5.4% range obtained by
others for rat brain HS [34]. Another group has found rat
cerebrum and cerebellum HS to have between 6–8% of D2S6
[35]. Similar abundances are observed in mouse brain [4]. It is
likely that the small differences in results obtained using SEC LC/
MS and other methods arise from the samples and the biases of
the tissue extraction methods used in each laboratory.
The abundances of HS D
4,5-unsaturated disaccharides before
and after digestion with HSulf2 as determined using SEC LC/MS
are shown in Fig. 1A. The relative abundances of control or
HSulf2 treated disaccharides were calculated from peak area
integration of EICs of disaccharides eluting from the SEC column.
As expected, HSulf2 treated HS displayed a decrease in the
abundance of D2S6, the principal disaccharide substrate of the
Sulfs [9,10].
The relative changes in the abundance of two pairs of isobaric
disaccharides was determined using tandem MS, following the
rationale of previously developed methods [36,37]. The data show
a small decrease in the D2A0/D0A6 pair due to HSulf2 digestion
(Fig. 1B). The D0A6 abundance of this pair, as determined using
tandem MS, decreased in all samples except for intestine. These
results demonstrate that D0A6 is a target for HSulf2. The
percentage of D0S6 in the D2S0/D0S6 isomer pair decreased
dramatically resulting from HSulf2 treatment, as determined using
tandem mass spectrometry (Fig. 1C). The data are consistent with
the conclusion that HSulf2 converts D2S6 to D2S0 and D0S6 to
D0S0. The overall increase in abundance of the D2S0/D0S6 pair
is due to the increase in the abundance D2S0. The abundances of
D0A0 are the same before and after HSulf2 treatment for all
organs. This result demonstrates that HSulf2 digestion does not
bias the activity of the heparin lyase enzymes used to depolymerize
HS.
Changes in the profile of internal, D
4,5-unsaturated disaccha-
rides from the HSulf2 treated bovine organ HS samples are shown
in Fig. 2. The differences are displayed as a natural log fold-change
between control and HSulf2 treated samples. The abundance of
each disaccharide, averaged over the five HS sources, is shown as
a percentage of all D
4,5-unsaturated disaccharides on the graph. As
mentioned, the trisulfated disaccharide, D2S6, decreased in
abundance for all organ HS populations. This change, however,
occurred in an organ specific manner, with the greatest decrease
occurring for bovine 1.25 M kidney HS, and the smallest decrease
occurring for bovine aorta HS. The abundance of D2A6, a
disaccharide found in NA/NS domains, was also significantly
decreased in the organ HS populations, with the exception of HS
from bovine intestine. Two other 6O-sulfate containing disaccha-
rides, D0A6 and D0S6, occur as isomer pairs (with D2A0 and
D2S0, respectively) in the MS mode.
Glycomics of HSulf2 Activity
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chains were also quantified using SEC-LC/MS, and differences in the
abundance before and after treatment with HSulf2 are shown in Fig. 3.
The abundance for each disaccharide, averaged over the five HS
sources, is shown as a percent of all saturated disaccharides on the
graph. This information can be used to evaluate the changes induced
by HSulf2 at HS termini. The change in the amount of U2S6 (the
saturated counterpart of D2S6) observed at the NRE after HSulf2
treatment differed from the change in D2S6 observed from the internal
regions of the HS chains (Fig. 2). More specifically, the changes
observed for U2S6 for bovine intestine and lung were much greater
than for D2S6. Overall, saturated disaccharides represent a small
fraction of the total disaccharides liberated by heparin lyases. The low
MS ion abundances for saturated disaccharides preclude tandem MS
experiments used for differentiation of disaccharides that occur as
isomer pairs. Despite this, there are readily apparent differences in the
profile of the U0S6/U2S0 isobar at the NRE compared to internal
regions after HSulf2 treatment. The abundance of U0S6/U2S0 is
lower for all samples following HSulf2 digestion, and this is
accompanied by an increase in the abundance of U0S0. Again, these
changes are organ specific. U2A6 was lower in abundance at the NRE
for both of the bovine kidney samples, and only slightly less abundant
for intestine, aorta and lung HS. An experiment using inactivated
HSulf2 showed no changes in the abundances of HS disaccharides
following lyase digestion, relative to samples in which no HSulf2 was
added. These results show that the experimental digestion and workup
conditions did not cleave or otherwise modify the HS chains.
Maccarana et. al. have previously analyzed the same pool of
bovine HS samples [11] by profiling disaccharides produced from
nitrous acid depolymerization. Under the conditions they used,
disaccharides originating from NS domains were liberated from
the HS chains. These data can be used to determine the profile of
disaccharides that reside within these highly sulfated domains. We
combined this information with the current data to determine the
change in degree of sulfation for the NS domains of each of the
bovine HS substrates that would occur upon treatment with
HSulf2, as shown in Fig. 4. The black bars show the change in NS
domain degree of sulfation that would occur if all NS domain 6O-
sulfates were liberated by HSulf2. The changes in degrees of
sulfation of NS domains that occur based on the current
disaccharide analysis (Fig. 1) are shown in the white bars in
Fig. 4. In all cases, the observed change in degree of sulfation does
not reach the maximum possible value. The patterns for decrease
in NS domain degree of sulfation are organ specific. Additionally,
there are differences between the patterns observed for the extent
of change in degree of sulfation when comparing the maximum vs.
observed scenarios. For example, the order of percent decrease in
degree of sulfation for the observed scenario is aorta , intestine ,
lung ,1.1 M kidney ,1.25 M kidney while the order for the
maximum scenario is intestine , aorta , lung/1.1 M kidney
,1.25 M kidney.
Of additional interest was the editing of the fine structure of
other mammalian HS substrates by HSulf2. These experiments
would determine whether the trends we observed for the editing of
bovine HS by HSulf2 were also true for HS isolated by different
approaches and from different animals. To this end, murine
kidney and liver HS, known to be among the most sulfated of HS
populations from this organism [4], were analyzed. Murine liver
Figure 2. Fold change plot of the abundances of D
4,5-unsaturated disaccharides from control and HSulf2 treated bovine HS
samples. Disaccharide abundances from Fig. 1A are shown as fold-change differences relative to control samples. Error bars are calculated from
triplicate experiments and are reported as +/2 S.D.
doi:10.1371/journal.pone.0016689.g002
Figure 1. Disaccharide abundances before and after HSulf2 digestion. (A) Abundances of D
4,5-unsaturated disaccharide abundances from
control and HSulf2 treated HS. Peak areas were determined by integration of extracted ion chromatograms for each of the structures indicated on the
X axis. Error bars are calculated from triplicate experiments and are reported as +/2 S.D. Two 6O-sulfated disaccharides, D0S6 and D0A6, occur as
isomer pairs with D2S0 and D2A0, respectively. Tandem MS was used to determine the percent abundance of each 6O-sulfated disaccharide (within
its isobar), before and after HSulf2 treatment. (B) The percent abundance of D0S6 in the D2S0/D0S6 isomer pair before and after HSulf2 treatment. (C)
The relative abundance of D0A6 in the D2A0/D0A6 isomer pair before and after HSulf2 treatment.
doi:10.1371/journal.pone.0016689.g001
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measured previously as high as 17.0% and currently as 19.4% of
total disaccharide content. Changes in the profile of D
4,5-
unsaturated disaccharides produced from exhaustive heparin lyase
digestion of murine HS with and without HSulf2 treatment are
shown in Fig. 5A. The abundance of each disaccharide, averaged
over the two HS sources, is shown as a percentage of all D
4,5-
unsaturated disaccharides on the graph. Interestingly, the pattern
of change in the disaccharides after HSulf2 treatment is very
similar to that observed for bovine HS (Fig. 2). Tandem MS
revealed only modest desulfation of D0A6 from the murine
samples (Fig. 5B), which was observed as 11.1% for liver and 5.6%
Figure 3. Fold change plot of the abundances of saturated disaccharides from control and HSulf2 treated bovine HS samples.
Control or HSulf2 treated bovine HS samples were analyzed using SEC-MS. Changes in disaccharide abundance after HSulf2 treatment are shown as a
fold-change difference. The changes in the abundance of U0A6 and U0S6 with respect to their isobars cannot be determined due to the low
abundance of saturated disaccharides. Error bars are calculated from triplicate experiments and are reported as +/2 S.D.
doi:10.1371/journal.pone.0016689.g003
Figure 4. Changes in degree of sulfation of bovine HS NS domains due to HSulf2 digestion. The maximum possible change in the degree
of sulfation (sulfates per disaccharide unit) of NS domains from bovine HS chains after HSulf2 treatment (black bars) was calculated, based on
previously quantified nitrous acid depolymerization products generated from the same sample pool [11]. This is compared to the change in degree of
sulfation calculated based on the disaccharide data generated during the current study (Fig. 1A).
doi:10.1371/journal.pone.0016689.g004
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desulfation of D0S6 occurred (Fig. 5C). The decreases in
abundance of this disaccharide were 55.8% and 51.5% for liver
and kidney, respectively.
HSulf2 induced similar changes to the NRE of murine HS as it
did to the NRE of bovine HS, as shown in Fig. 6. The abundance
of each disaccharide, averaged over the two HS sources, is shown
as a percentage of all saturated disaccharides on the graph. For
murine kidney and liver HS, the fold change of U2S6 detected at
the NRE after HSulf2 treatment is similar to that of the
corresponding internal disaccharide, D2S6 (Fig. 5A). The decrease
in the abundance of the U0S6/U2S0 isobar observed at the NRE
of bovine organ HS chains is also present for the murine HS
preparations. U2A6 decreased in abundance following HSulf2
treatment in the case of murine kidney, but not for murine liver.
To further characterize the changes induced at the NRE of HS
by HSulf2, the total abundance of D
4,5-unsaturated or saturated
disaccharides was compared before and after treatment of the
samples with HSulf2. The mass spectral abundances from the SEC
separations are expressed as a fold change for both bovine (Fig. 7A)
and murine (Fig. 7B) HS samples. Small increases in the
abundance of D
4,5-unsaturated disaccharides were detected
following HSulf2 treatment. Comparatively large increases were
observed, however, for saturated disaccharides.
To assess the possible origin of the increase in saturated structures,
lyase resistant tetrasaccharides were examined. The SEC-UV traces
showed small increases in absorbance in the range of elution time that
corresponds to elution of tetrasacc h a r i d e s( F i g .S 2 ) .T h eS E CL C / M S
data detected one major tetrasaccharide composition in all samples,
[1,1,2,3,0] (the tetrasaccharide composition is given as [DHexA, Hex,
GlcN, Sulfate, Acetate]), along with its saturated counterpart,
[0,2,2,3,0]. The abundances of these structures were considerably
higher in the bovine samples, and were too low in the murine samples
for accurate quantitation. This is likely explained by the amount of HS
injected onto the LC/MS system (higher for bovine samples than for
murine samples, according to total ion counts) and the intensity of the
tetrasaccharides was proportional to the overall signal for all
disaccharides observed in the LC/MS datasets. With the exception
of bovine intestine, an increase in the abundance of [1,1,2,3,0] and
[0,2,2,3,0] was observed for all samples after treatment with HSulf2, as
shown in Fig. 8. The abundances of [1,1,2,3,0] and [0,2,2,3,0] are
observed to increase in the bovine HS populations treated with HSulf2,
except for bovine intestine HS. Interestingly, when compared to its
internal counterpart, [0,2,2,3,0] displayed a greater fold-change
increase in abundance.
These lyase-resistant oligosaccharides represent a small per-
centage of domains in HS chains. It is known that disaccharide
repeats containing a 3O-sulfated GlcN residue resist heparin lyase
cleavage [39]. Such residues are required for anticoagulant
function of heparin/HS. The changes in the abundances observed
in Fig. 8 that result from HSulf2 digestion indicated that the
presence of 6O-sulfate groups influences the susceptibility of the
oligosaccharides to lyase digestion. The SEC LC/MS system is
able to detect tetrasaccharides, while oligosaccharides of dp6 or
longer cannot be detected because of their highly polydisperse
nature. The data in Fig. 7 and Fig. 8 suggest that HSulf2 digestion
changes the susceptibility of HS chains to lyase digestion. The
increases in abundances for dp2 and dp4 in the HSulf2 digested
samples indicate that the overall susceptibility of the HS chains to
lyase digestion is increased by the removal of 6O-sulfate groups.
The data also show that the extent to which saturated dp2 and dp4
increase in abundance is greater than for their internal
Figure 6. Fold change plot of the abundances of saturated disaccharides from control and HSulf2 treated murine HS samples.
Control or HSulf2 treated murine HS samples were analyzed using SEC-MS. Changes in disaccharide abundance after HSulf2 treatment are shown as a
fold-change difference. The changes in the abundance of U0A6 and U0S6 with respect to their isobars cannot be determined due to the low
abundance of saturated disaccharides. Error bars are calculated from triplicate experiments and are reported as +/2 S.D.
doi:10.1371/journal.pone.0016689.g006
Figure 5. Fold change plot of the abundances of D
4,5-unsaturated disaccharides from control and HSulf2 treated murine HS
samples. Control or HSulf2 treated murine HS samples were analyzed using SEC-MS. (A) Disaccharide abundances after HSulf2 treatment are shown
as a fold-change difference relative to control samples. Two other 6O-sulfated disaccharides, D0A6 and D0S6, occur as isomer pairs with D2A0 and
D2S0, respectively. Tandem MS was used to determine the percent abundance of each 6O-sulfated disaccharide (within its isobar), before and after
HSulf2 treatment. (B) The relative abundance of D0A6 before and after HSulf2 treatment. (C) The relative abundance of D0S6 before and after HSulf2
treatment. Error bars are calculated from triplicate experiments and are reported as +/2 S.D.
doi:10.1371/journal.pone.0016689.g005
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activity towards the NRE than the internal oligosaccharides, taken
as an average. The data do not rule out that there may be
particular internal domains toward which HSulf2 is highly active.
Thus, it appears that NRE domains have increased susceptibility
towards HSulf2 relative to the average internal domains and that
this pattern is present in most organs samples studied.
Fig. 9A shows the total percentage of 6O-sulfate released from each
of the bovine or murine HS preparations as a function of the total
abundance of 6O-sulfates in each chain. In general, as the 6O-sulfate
content increases, so does the amount of 6O-sulfate released.
However, while murine liver, murine kidney, and bovine 1.25 M
kidney have similar total 6O-sulfate content, there is considerable
variation in the amount of 6O-sulfate released. The ability of HSulf2
to edit HS sulfation may be assessed in more detail by examining the
6O-desulfation of D2S6, as shown in Fig. 9B. This figure shows the
percent of 6O-desulfation of D2S6 as a function of the overall D2S6
content for a given preparation. The two bovine kidney preparations
exhibit the highest degree of 6O-desulfation despite the fact that their
initial D2S6 content is much lower than that of either murine kidney
or murine liver HS. This indicates that D2S6 is desulfated in a
manner dependant on the domain context in which it resides.
Discussion
Sulf1 and Sulf2 are thought to work cooperatively to regulate
developmental processes by modifying HS 6O-sulfate patterns
[16,18,40]. Redundancy in the roles of Sulf1 and Sulf2 is evident
from studies of double knock-out mice, where pups display severe
defects in esophageal development that result in death [16]. In
contrast, mice that are deficient in Sulf1 or Sulf2 alone survive,
albeit with some developmental defects [16,40,41]. The story is
complicated by the fact that in some cases, Sulf1 and Sulf2 are
differentially expressed, for example in the developing mouse brain
[41] and regenerating skeletal muscle [42] along with the fact that
the Sulfs may have different substrate specificities in vivo [13].
Figure 7. Influence of HSulf2 digestion on D
4,5-unsaturated and saturated disaccharide abundances following lyase
depolymerization. The abundances of total saturated and D
4,5-unsaturated disaccharides in control or HSulf2 treated samples were compared
and expressed as a LN fold change. (A) The fold-change in abundance of D
4,5-unsaturated (black bars) or saturated (white bars) disaccharides
subsequent to HSulf2 treatment of bovine HS samples. (B) The fold-change in abundance of D
4,5-unsaturated (black bars) or saturated (white bars)
disaccharides subsequent to HSulf2 treatment of murine HS samples. Error bars are calculated from triplicate experiments and are reported as +/2
S.D.
doi:10.1371/journal.pone.0016689.g007
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fine structure by the Sulfs is essential for developmental processes.
Recently, co-regulatory functions of the Sulfs were identified in
primary MEF cells. For example, up-regulation of mSulf1 was
observed in mSulf2
2/2 cells, as measured by real-time PCR and
Northern blot analysis. Additionally, down-regulation of mSulf2
was observed in mSulf1
2/2 cell lines [13]. Interestingly, these
effects were not observed in immortalized MEF cells [14].
However, the immortalized cells displayed altered gene expression
of HS 6O-, 2O-, and 3O-sulfotransferases [14]. Loss of Sulf2
resulted in a nearly three-fold decrease in HS2ST1 expression.
Currently, it is not understood how the Sulfs mediate effects on the
expression of HS biosynthetic enzymes. These phenomena make it
difficult to assess the structural changes in HS molecules that are
induced solely by the enzymatic activity of Sulf enzymes.
The characterization of the in vitro alteration of 6O-sulfation state by
HSulf2 on a set of HS substrates was thus initiated. The results serve to
increase the understanding of Sulf activity in vivo,w h e r et h eb i o l o g i c a l
functions of HS are determined by the organization of sulfation and
epimerization modifications along the chain. Disaccharide analysis
from bovine (Fig. 2) and murine (Fig. 5A) HS substrates reveals, as
expected, that HSulf2 is most active on the trisulfated disaccharide
species, D2S6. Another NS domain disaccharide, D0S6, is also
significantly 6O-desulfated by HSulf2. While the majority of HSulf2
activity is localized to NS domains, a measurable amount of activity
was detected in NA/NS domains. 6O-desulfation of D0A6 is observed
to occur for all substrates, except for bovine intestine. Additionally, 6O-
desulfation of D2A6, a disaccharide that is typically in very low
abundance in HS populations, is observed to occur for all substrates,
again with the exception of bovine intestine HS. In all cases, the degree
to which HSulf2 releases 6O-sulfate from either NA/NS domains or
NS domains varies from one substrate to another. This suggests that
desulfation of a given 6O-sulfate by HSulf2 is dependent on the domain
structure surrounding the target sulfate moiety. This appears to be
particularly true when comparing the desulfation of NS domains vs.
NA/NS domains, which each contain about half of the total 6O-sulfate
content of an HS chain [11].
The current data are consistent with a recent report that the
hydrophilic domain of the Sulfs binds HS chains with high affinity and
in a manner dependent on 6O-sulfation [43]. It was proposed that the
specificity of this interaction is a mechanism for targeting of the
catalytic domain of the Sulfs to the 6O-sulfates of an HS chain.
Additionally, it was proposed that multiple sites of contact would be
needed to stabilize the interaction of the hydrophilic domain with HS
chains, meaning that fine structure surrounding a given 6O-sulfate
would be a major determinant of Sulf substrate processing. These
features may explain the variation we observe in the HSulf2 processing
of the mammalian HS chains investigated in this study. It appears likely
that the catalytic activity of Sulfs is partially instructed by the HS
biosynthetic reactions that occur within a population of cells,
particularly by 6O-sulfotransferases.
A benefit of the use of MS for the current experiments is that, for
the first time, an assessment of Sulf activity at the NRE of HS chains
ispossible.ThedisaccharideanalysisresultsindicatethattheNREis
acted upon by HSulf2 to a higher degree, as compared to internal
regionsof the chain(Fig. 3 forbovine HSand Fig. 6 for murineHS).
This difference in HSulf2 action at the NREs is likely to influence
protein-binding events that occur at this location. The interaction of
FGF2 with FGFR and HS chains is a particularly relevant example
in this case, because alterations in 6O-sulfation state caused by
disruption of 6O-sulfotransferase expression have been shown to
have drastic effects on FGF2 signaling [44]. Similarly, alteration of
the 6O-sulfation state of HS by Sulfs has been shown to affect
formation of the FGF:FGFR:HS ternary complex [25]. In this case,
Sulf activity serves to attenuate FGF2 signaling. One of the current
models of FGF signaling implicates the NRE as a key location of
FGF:HS:FGFR ternary complex formation [45,46,47]. In this,
‘‘cooperative end structures’’ model, two 1:1:1 FGF:HS:FGFR
ternary complexes form a dimer, dependent on the NREs of
separate HS chains. The altered activity of HSulf2 at the NRE of
Figure 8. Effect of HSulf2 digestion on abundances of lyase-resistant tetrasaccharides in exhaustive digests of bovine HS. Two
tetrasaccharides that resist exhaustive lyase digestion were quantified in control and HSulf2 treated bovine HS samples. The black bars show the fold
change in abundance of [1,1,2,3,0]. The white bars show the fold change in abundance of [0,2,2,3,0]. Error bars are calculated from triplicate
experiments and are reported as +/2 S.D.
doi:10.1371/journal.pone.0016689.g008
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regulator of FGF ternary complex formation at the NRE.
It will be of interest to extend the current studies to an examination
of oligosaccharides derived from tissue-specific HS samples. Such
oligosaccharides correspond to HS domains and their analysis will
determine how Sulf activity modifies HS structure in a more global
context. Additionally, MS protein-binding characterizations (akin to
those already carried out for antithrombin III [48,49]) between the
hydrophilic domain of Sulfs and HS substrates will be very useful for
determining the requirements for HS binding and editing by the Sulfs.
This will provide further understanding of how the Sulfs modify the
activity or concentration of signaling molecules at the cell surface.
Materials and Methods
Materials
HS from bovine aorta, lung, intestine, and two fractions from kidney
that were purified using two different concentrations of salt (1.1 M or
1.25 M NaCl) for elution from anion exchange chromatography were
a generous gift from Dr. Keiichi Yoshida. Murine liver and kidney HS
were a generous gift from Dr. Fuming Zhang and Dr. Robert
Linhardt. Recombinant HSulf2 was a generous gift from Shire Human
Genetic Therapies (Cambridge, MA). Heparin lyases I, II, and III were
from Ibex (Montreal, Quebec, Canada). HS disaccharide standards
and all other reagents were from Sigma-Aldrich (St. Louis, MO).
Treatment of heparan sulfate with HSulf2
HS samples, ,50 mg each, were dissolved in 90 mL of 100 mM
NaCl, 20 mM Tris, 1mM CaOAc, 1 mM MgCl2, pH 7.4 and a
10 mL aliquot of Sulf2, which contained 10 mg of enzyme in
storage buffer (20 mM sodium phosphate, 500 mM NaCl, 10%
glycerol, 0.5 mg/mL pefabloc, pH 7.0) was added. The reaction
was allowed to proceed overnight at 37uC. Subsequently, the
reaction was heat inactivated by boiling for 3 min and stored at
220uC prior to complete depolymerization using heparin lyases.
Preparation of D
4,5-unsaturated heparan sulfate
disaccharides
Untreated and HSulf2 treated HS samples (,10 mg each) were
exhaustively digested using a mixture of 2 mIU each of heparin
Figure 9. Comparison of the extent of HSulf2 mediated release of 6O-sulfate from bovine and murine HS samples. The release of 6O-
sulfate from the various HS samples was determined by summing the decreases in abundance of 6O-sulfated disaccharides (Fig. 1A and Fig. 5A). (A)
The release of 6O-sulfate by HSulf2 as a function of total 6O-sulfate content in the control samples. (B) The release of 6O-sulfate from D2S6 after
HSulf2 treatment as a function of total D2S6 content in the control samples.
doi:10.1371/journal.pone.0016689.g009
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NaCl, 20 mM Tris, 1mM CaOAc, 1 mM MgCl2, pH 7.4.
Another aliquot of heparin lyases was added after two hours of
incubation and the reaction was allowed to proceed overnight.
The reaction was terminated by heat inactivation.
SEC-LC/MS analysis of HSulf2 treated heparan sulfate
disaccharides
Heparin lyase depolymerized control or HSulf2 treated HS
samples were analyzed directly after digestion using SEC-LC/MS
[30]. Briefly, HS samples (,1 mg per replicate) were injected onto
a Superdex Peptide PC 3.2/30 column (GE Biosciences, Piscat-
away, NJ) online with an Applied Biosystems/MDS Sciex QSTAR
Pulsar Qq-TOF mass spectrometer operating in the negative-ion
mode. The isocratic mobile phase was 12.5 mM formic acid,
titrated to pH 4.4 with ammonia, in 10% acetonitrile. The SEC
LC/MS system is able to detect disaccharides quantities as low as
100 femtomole and perform routine quantitation of disaccharides
from 1 pmol to 1 nmol. To differentiate isomeric disaccharides,
tandem SEC-LC/MS experiments were performed. These
experiments were separate from the runs used for glycoform
quantitation described above, and utilized principles developed in
previous studies for distinguishing isomeric HS or chondroitin
sulfate structures [36,37]. Commercial disaccharides were used as
quantitative standards for the tandem mass spectra. Briefly, mock
binary mixtures of D0A6/D2A0 and D0S6/D2S0 were prepared
in ratios of 3:0, 3:1, 2:1, 1:1, 1:2, 1:3, 0:3. Tandem mass spectra
were acquired using a collision energy of 40 V. The signals were
averaged across the most abundant region of the chromatographic
peak (60.75 min of the center). Diagnostic ions were selected for
each pair of isomers. For HS D0A6/D2A0: m/z 139 and 157,
respectively; for D0S6/D2S0: m/z 157 and 199, respectively. The
intensities of each diagnostic ion were normalized to the sum of the
signal for a given isomer pair. The data for each binary mixture
were plotted, and exponential regression was used to fit a curve to
the data using Igor Pro 4.07 (Wavemetrics, Portland, OR).
Tandem SEC-LC/MS experiments were carried out for all
control and HSulf2 treated samples. The relative abundances of
the diagnostic ions of each isomeric pair were obtained and were
substituted into the fitted equation to produce the relative
contribution of a disaccharide to its isobar.
Supporting Information
Figure S1 Codes for disaccharides used in this work. The
monosaccharides residues are defined using the symbols shown at
the bottom of the figure. The position(s) of sulfation on each
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